Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
The system is powered by BrainSense technology, which has received approval from USFDA
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
PMDA is regarded among the most stringent regulatory bodies globally
Muted movement reflects consolidation phase as investors await earnings triggers
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
A brand from Opella will be part of the official NASA astronaut formulary
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
Subscribe To Our Newsletter & Stay Updated
